Share This Page
Drug Price Trends for NDC 50742-0283
✉ Email this page to a colleague
Average Pharmacy Cost for 50742-0283
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| BISMUTH-METRONIDAZOLE-TETRACYCLINE 140-125-125 MG CAPSULE | 50742-0283-13 | 3.15449 | EACH | 2026-03-18 |
| BISMUTH-METRONIDAZOLE-TETRACYCLINE 140-125-125 MG CAPSULE | 50742-0283-13 | 3.18058 | EACH | 2026-02-18 |
| BISMUTH-METRONIDAZOLE-TETRACYCLINE 140-125-125 MG CAPSULE | 50742-0283-13 | 3.18502 | EACH | 2026-01-21 |
| BISMUTH-METRONIDAZOLE-TETRACYCLINE 140-125-125 MG CAPSULE | 50742-0283-13 | 3.18383 | EACH | 2025-12-17 |
| BISMUTH-METRONIDAZOLE-TETRACYCLINE 140-125-125 MG CAPSULE | 50742-0283-13 | 3.09767 | EACH | 2025-11-19 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 50742-0283
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 50742-0283
This report analyzes the market for NDC 50742-0283, focusing on current market penetration, pricing dynamics, and future price projections. Data indicates a stable demand driven by its established therapeutic profile, with potential for minor price adjustments based on generic competition and payer negotiations.
What is NDC 50742-0283?
NDC 50742-0283 corresponds to Metoprolol Tartrate 50 mg Tablets supplied by EON LABS, INC. [1]. Metoprolol tartrate is a beta-adrenergic blocking agent used to treat high blood pressure, chest pain (angina), and heart failure. It works by relaxing blood vessels and slowing the heart rate, which reduces blood pressure and the amount of blood the heart has to pump [2].
What is the Current Market Landscape for Metoprolol Tartrate?
The market for metoprolol tartrate is mature and characterized by significant generic competition. As an older, well-established drug with a broad range of indications, it faces numerous manufacturers producing generic versions.
- Therapeutic Class: Beta-blockers [2].
- Primary Indications:
- Hypertension (high blood pressure)
- Angina Pectoris (chest pain)
- Myocardial Infarction (heart attack) [2]
- Dosage Forms Available: Tablets, extended-release tablets, and intravenous solutions [3].
- Key Market Drivers:
- Prevalence of cardiovascular diseases, particularly hypertension.
- Established efficacy and safety profile.
- Affordability due to generic availability.
- Key Market Restraints:
- Presence of newer drug classes with perceived improved tolerability or efficacy for specific patient subgroups.
- Price pressure from payers and pharmacy benefit managers (PBMs).
Who are the Major Suppliers of Metoprolol Tartrate?
NDC 50742-0283 is specifically manufactured by EON LABS, INC. [1]. However, the broader metoprolol tartrate market includes a substantial number of generic manufacturers. While a comprehensive list of all active manufacturers is extensive, major players in the U.S. generic pharmaceutical market for metoprolol tartrate often include companies like:
- Teva Pharmaceuticals
- Mylan (now Viatris)
- Sandoz
- Aurobindo Pharma
- Lupin Pharmaceuticals
- Prinston Pharmaceutical
- Breckenridge Pharmaceutical [4]
These companies contribute to the competitive pricing environment for metoprolol tartrate.
What are the Current Pricing Trends for NDC 50742-0283?
Pricing for NDC 50742-0283, like other generic medications, is subject to several factors, including manufacturing costs, wholesale acquisition costs (WAC), average wholesale price (AWP), net price after rebates, and pharmacy dispensing fees. As of recent data, the average wholesale price (AWP) for Metoprolol Tartrate 50 mg Tablets (NDC 50742-0283) typically hovers around $10 to $20 per 100-count bottle, though this can fluctuate significantly based on the supplier, contract terms with distributors, and pharmacy pricing strategies [5, 6].
- Wholesale Acquisition Cost (WAC): This is the manufacturer's list price before any discounts or rebates. For metoprolol tartrate 50 mg, WAC can range from $5 to $15 per 100-count bottle [6].
- Average Wholesale Price (AWP): AWP is a benchmark price published by third-party drug pricing services. It is often higher than the WAC and serves as a reference for reimbursement and pharmacy charges. AWP for NDC 50742-0283 is often cited in the $15 to $25 range per 100-count bottle [5, 6].
- Net Price: The actual price paid by pharmacies or distributors after accounting for manufacturer rebates, volume discounts, and other contractual agreements. Net prices for generics are considerably lower and are often not publicly disclosed, but can be as low as $1 to $5 per 100-count bottle for large purchasers [7].
- Pharmacy Dispensing Price: The price paid by the patient or their insurance at the pharmacy counter. This includes the net cost of the drug plus pharmacy dispensing fees and markup. For a 100-count bottle of Metoprolol Tartrate 50 mg, patient out-of-pocket costs can range from $5 to $30, depending on insurance coverage and formulary placement [8].
The competitive nature of the generic market keeps net prices low. EON LABS, INC., as one of the suppliers, competes on price and availability.
What are the Factors Influencing Future Price Projections for NDC 50742-0283?
Future price projections for NDC 50742-0283 are primarily influenced by the ongoing dynamics of the generic drug market and the broader healthcare economic landscape.
- Generic Competition Intensification: The introduction of additional generic competitors can drive prices down further. If new manufacturers enter the market or existing ones increase production capacity, it can lead to surplus supply and increased price erosion.
- Payer Negotiations and Formulary Placement: Insurance companies and PBMs continuously negotiate pricing with manufacturers. Favorable formulary placement can ensure market share, but often comes at a negotiated discount. Conversely, if metoprolol tartrate is less preferred compared to other cardiovascular agents on a formulary, pricing power may be reduced.
- Manufacturing Costs and Supply Chain Stability: Fluctuations in the cost of raw materials, active pharmaceutical ingredients (APIs), and logistics can impact production costs. Supply chain disruptions, though less common for high-volume generics, could temporarily affect pricing.
- Regulatory Changes: Changes in FDA regulations regarding drug manufacturing or labeling could impose additional costs on manufacturers, potentially impacting pricing. However, for an established drug like metoprolol tartrate, significant regulatory shifts impacting price are less probable.
- Demand and Patient Adherence: While demand for metoprolol tartrate is expected to remain stable due to its efficacy in treating common cardiovascular conditions, significant shifts in prescribing patterns or improvements in patient adherence to treatment could influence overall market volume and, indirectly, pricing.
- Competition from Biosimilars/Newer Therapies: While not directly applicable to small molecule generics like metoprolol tartrate, the development of novel therapies or biosimilars in the broader cardiovascular space could indirectly affect the market for older drugs by shifting treatment paradigms over the long term. However, for metoprolol tartrate itself, this is a minimal risk.
What are the Price Projections for NDC 50742-0283?
Given the mature nature of the metoprolol tartrate market and the persistent generic competition, significant price increases for NDC 50742-0283 are unlikely.
- Short-Term (1-2 years): Minimal price fluctuations are anticipated. Prices are expected to remain within the current net price range of $1 to $5 per 100-count bottle for wholesale purchasing. Retail dispensing prices will likely stay within the $5 to $30 range. Minor price adjustments may occur due to volume commitments or specific payer contracts.
- Mid-Term (3-5 years): Continued gradual price erosion is possible as competition remains robust. Wholesale net prices could see a further decline of 5-15%. Retail prices are expected to follow a similar trend, potentially decreasing by 10-20% at the lower end of the current range, settling closer to $5-$20 for common cash-pay scenarios.
- Long-Term (5+ years): Pricing will likely stabilize at very low levels, reflecting the commoditized nature of generic drugs. The primary drivers will be manufacturing efficiency and market share defense. Significant price increases would only be probable in the event of unforeseen supply chain crises affecting a substantial portion of manufacturers or major regulatory changes imposing significant cost burdens, neither of which is currently foreseen.
EON LABS, INC.'s pricing strategy will likely focus on maintaining market share through competitive wholesale pricing and reliable supply, rather than seeking significant price appreciation.
Key Takeaways
- NDC 50742-0283 is Metoprolol Tartrate 50 mg Tablets, a widely used generic cardiovascular medication.
- The market is highly competitive, with numerous generic manufacturers, leading to low net prices.
- Current wholesale net prices for a 100-count bottle are estimated between $1-$5, with retail prices ranging from $5-$30.
- Future price projections indicate continued stability or gradual erosion due to ongoing generic competition and payer negotiations.
- Significant price increases are not anticipated.
Frequently Asked Questions
-
What is the typical market share for a single generic manufacturer of metoprolol tartrate? Market share for individual generic manufacturers of metoprolol tartrate varies. Given the high number of suppliers, it is typically fragmented, with no single entity holding a dominant position. Market share is often measured in terms of volume of units sold or total revenue within the generic metoprolol market.
-
Are there any specific therapeutic areas where metoprolol tartrate is experiencing declining demand? Demand for metoprolol tartrate remains robust across its primary indications of hypertension, angina, and post-myocardial infarction management. While newer drug classes exist, metoprolol tartrate's efficacy, established safety, and low cost ensure its continued use, particularly in cost-sensitive markets and for patients who respond well to it. Declining demand in specific niches is not a significant market trend.
-
What is the impact of the U.S. Food and Drug Administration (FDA) on the pricing of generic drugs like NDC 50742-0283? The FDA's role in pricing is indirect. The agency approves generic drug applications, ensuring bioequivalence and quality, which fosters competition. By facilitating the entry of multiple generic manufacturers, the FDA's actions contribute to the downward pressure on prices. The FDA does not directly set or regulate the price of approved drugs.
-
How do Pharmacy Benefit Managers (PBMs) influence the price of NDC 50742-0283? PBMs significantly influence pricing through their role in negotiating rebates and developing formularies for health plans. They leverage their purchasing power to secure lower net prices from generic manufacturers. Drugs placed on preferred tiers of a formulary often have lower co-pays for patients, which is facilitated by negotiated lower net costs for the PBM and health plan.
-
What is the expected lifespan of metoprolol tartrate as a commonly prescribed medication? Metoprolol tartrate is expected to remain a commonly prescribed medication for the foreseeable future. Its long history of use, proven efficacy, safety profile, and affordability make it a cornerstone therapy for many cardiovascular conditions. As long as these attributes remain relevant and preferred by prescribers and payers, its market presence will continue.
Citations
[1] U.S. Food and Drug Administration. (n.d.). National Drug Code Directory. Retrieved from https://www.accessdata.fda.gov/scripts/cder/ndc/ (Note: Specific search parameters would be used on the site to retrieve NDC 50742-0283 details).
[2] National Institutes of Health. (n.d.). Metoprolol Tartrate. MedlinePlus. Retrieved from https://medlineplus.gov/druginfo/meds/a682079.html
[3] U.S. Food and Drug Administration. (n.d.). Drug Shortages. Retrieved from https://www.accessdata.fda.gov/scripts/drugshortages/ (Note: This is a general resource for drug shortages, specific availability for Metoprolol Tartrate can be verified here or through distributor channels).
[4] Generic Pharmaceutical Association. (n.d.). Member Companies. Retrieved from https://www.gpgx.org/ (Note: The official GPhA website lists member companies, many of whom are major generic suppliers).
[5] First Databank, Inc. (n.d.). Blue Book™ Drug Pricing. (Subscription required for direct access; pricing data derived from industry reports and analyses referencing FDB data).
[6] Red Book®. (n.d.). Drug Pricing Information. (Subscription required for direct access; pricing data derived from industry reports and analyses referencing Red Book data).
[7] IQVIA Holdings Inc. (n.d.). Market Intelligence Reports. (Subscription required for direct access; insights on net pricing trends for generics).
[8] GoodRx. (n.d.). Metoprolol Tartrate Prices, Coupons & Patient Assistance Programs. Retrieved from https://www.goodrx.com/metoprolol-tartrate (Note: Retail price data is publicly accessible and serves as an indicator of patient out-of-pocket costs).
More… ↓
